A new analysis from the SCOPE consortium evaluates stroke prevention and atrial fibrillation risk after PFO closure in young ...
CHICAGO, Nov 15 (Reuters) - NMT Medical Inc's catheter system that seals a hole in the heart worked no better than drugs to prevent stroke in a study, suggesting physicians perform too many closure ...
The population of patients undergoing patent foramen ovale (PFO) closure in the US doesn’t match those of the clinical trials that formed the basis of the US Food and Drug Administration’s approval of ...
New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small hole in the heart) in patients with atrial fibrillation (AF) undergoing ...
Efficacy Outcome: Zero recurrent strokes or TIAs were observed across all 703 patients during the four-year follow-up period. Safety Profile: Noblestitch™ exhibited a robust safety profile with no ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
SAN DIEGO, Jan. 27, 2026 /PRNewswire/ -- BURL Concepts, a private MedTech company developing a rapid, automated and affordable test for evaluating cerebral blood flow and detecting emboli, announced ...
(Reuters) - A clinical trial evaluating St. Jude Medical Inc's implantable device used to prevent stroke in patients who have a common congenital heart defect failed to achieve its main goal. St. Jude ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results